SETD2 and cancer: In SETD2, the T2338Hfs*31 mutation appears recurrently in exon regions (n = 2), which may indicate mutation hotspots within specific functional domains of the protein, potentially impacting chromatin modification functions critical to cancer biology in chordoma.